Stryker Corporation

SYK · New York Stock Exchange · USD

325,73USD

−0,14 (−0,04 %)Stand 9. Nov., 21:02

Vortag 325,87

Kennzahlen

Eröffnung
328,88
Vortag
325,87
Tagesspanne
324,66 – 329,97
52 Wochen
267,00 – 389,33
Volumen
2,55 Mio.
Ø Volumen
2,72 Mio.
Börsenwert
124 Mrd. $
KGV
–
Gewinn je Aktie (TTM)
9,39
Dividendenrendite
–
Beta
0,8
Nächste Zahlen
–

Finanzen

USDFY 2025FY 2024FY 2023FY 2022FY 2021
Umsatz25,12 Mrd.22,6 Mrd.20,5 Mrd.18,45 Mrd.17,11 Mrd.
Herstellungskosten9,05 Mrd.8,05 Mrd.8 Mrd.7,41 Mrd.6,4 Mrd.
Bruttogewinn16,07 Mrd.14,55 Mrd.12,49 Mrd.11,04 Mrd.10,71 Mrd.
Forschung und Entwicklung1,58 Mrd.1,47 Mrd.1,29 Mrd.1,23 Mrd.1,13 Mrd.
Vertrieb und Verwaltung8,65 Mrd.7,5 Mrd.6,92 Mrd.6,08 Mrd.5,81 Mrd.
Operatives Ergebnis4,89 Mrd.3,69 Mrd.4,28 Mrd.3,73 Mrd.3,76 Mrd.
EBITDA6,31 Mrd.6,01 Mrd.5,06 Mrd.4,02 Mrd.3,61 Mrd.
Nettogewinn3,25 Mrd.2,99 Mrd.3,17 Mrd.2,36 Mrd.1,99 Mrd.
Gewinn je Aktie (verwässert)8,407,768,256,175,22

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

CEO
Kevin A. Lobo
Mitarbeitende
56.000
Hauptsitz
Portage, MI, US
Sektor
Healthcare
Branche
Medical - Devices
Börsengang
17. März 1980

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.